Pfizer vaccine appears effective against virus mutations, study finds

Scientists used blood samples from 20 people who received the Pfizer vaccine, made by Pfizer and its German partner BioNTech, during a large study of shots.



The COVID-19 vaccine developed by Pfizer Inc. and its German partner BioNTech appears to work against one of the most infectious mutations in the highly transmissible variants of coronavirus discovered in the U.K. and South Africa, according to a laboratory study.

New research suggests that the Pfizer vaccine has been effective against the N501Y mutation of the novel coronavirus. The study has been conducted by Pfizer along with researchers from the University of Texas Medical Branch.

Pfizer vaccine effective against key mutations, study shows 

Pfizer/BioNTech’s COVID-19 vaccine ‘BNT162b2’ has worked against 16 different virus mutations. “So we’ve now tested 16 different mutations, and none of them have really had any significant impact. That’s the good news. That doesn’t mean that the 17th won’t,” said Phil Dormitzer, one of Pfizer’s top viral vaccine scientists.

Pfizer vaccine coronavirus vaccine COVID-19 virus mutations

Pfizer/BioNTech’s COVID-19 vaccine ‘BNT162b2’ has worked against 16 different virus mutations.

The not-yet peer reviewed study was conducted on blood samples taken from people who had been given the Pfizer vaccine. Its findings are limited as it does not look at the full set of mutations found in either of the new variants of the rapidly developing novel coronavirus.

The researchers plan to run similar tests to see if the vaccine is effective against other coronavirus variants and mutations found in the U.K. and South Africa and hope to have more data within weeks.

Dormitzer noted another mutation found in the South African COVID variant to be dangerous. It may reduce the ability of antibodies to bind the virus and could make Pfizer’s BNT162b2 less effective.

If the virus eventually mutates enough that the vaccine needs tweaking, the new recipe wouldn’t be difficult to develop for Pfizer’s BNT162b2 shot and similar ones. The COVID-19 vaccine is made using a piece of the virus genetic code which is pretty simple to switch. It’s unclear what kind of additional testing FDA made require to make the new recipe.

Dormitzer said this is only the beginning of “ongoing monitoring of virus changes to see if any of them might impact on vaccine coverage.”

Coronavirus Mutation is Worrying 

Scientists have expressed concern that FDA-approved COVID-19 vaccines may still not be able to protect against the new variants, particularly the virus variant found in South Africa.

The Pfizer/BioNTech coronavirus vaccine and the one from Moderna Inc. which use synthetic messenger RNA technology can be quickly tweaked to address new virus mutations if necessary. Scientists have suggested the changes could be made within six weeks.

Drugmakers are keen to test their COVID-19 vaccines against the new variants of the coronavirus that are spreading fast.

Subscribe to the nation’s fastest-growing CEO magazine to get the latest business news delivered to your inbox. 

Avatar
Anna Domanska
Anna Domanska is an Industry Leaders Magazine author possessing wide-range of knowledge for Business News. She is an avid reader and writer of Business and CEO Magazines and a rigorous follower of Business Leaders.

Recent Posts

New Shepard Rocket launches Successful Test Liftoff

New Shepard Rocket launches Successful Test Liftoff

The New Shepard rocket by Blue Origin successfully conducted the test launch in the Texas testing site, successfully performing take-off and...
4 hours ago
MIT unveils Modern Design for Hybrid-Electric Airliner

MIT unveils Modern Design for Hybrid-Electric Airliner

Engineers at MIT conceptualized a hybrid-electric plane that would reduce nitrogen oxide emission levels and harmful greenhouse gases signif...
4 hours ago
Store Closures Cost European Retail Giant Primark $1.43 Billion in Sales

Store Closures Cost European Retail Giant Primark $1.43 Billion in Sales

The European retail giant Primark said the COVID-19 had caused a loss of over $1.43 billion (£1.05 billion) in sales from store closures. T...
1 day ago
Goldman Sachs to concentrate on consumer banking arm Marcus for growth

Goldman Sachs to concentrate on consumer banking arm Marcus for growth

Goldman Sachs Group Inc. is firming up plans to bolster its consumer banking arm Marcus through acquisitions and concentrating on digital ba...
1 day ago
General Electric claims Siemens Energy used stolen theft secrets to win contract bids

General Electric claims Siemens Energy used stolen theft secrets to win contract bids

General Electric Co. has accused rival Siemens Energy AG of using stolen trade secrets to rig bids for lucrative contracts supplying gas tur...
2 days ago
U.S. Trade Department Slams Digital Services Tax

U.S. Trade Department Slams Digital Services Tax

The U.S. Trade Representative on Thursday said that the Digital Service Taxes (DSTs) in Spain, Austria and the U.K. is unreasonable and disc...
2 days ago